Comparison of the effect of continuous intravenous infusion of prostaglandins E1, E2, I, or 6-keto-PGF1 alpha on lower esophageal sphincter pressure.
D015121:6-Ketoprostaglandin F1 alpha; D000818:Animals; D002415:Cats; D003864:Depression, Chemical; D011464:Epoprostenol / Q000494:pharmacology; D004943:Esophagogastric Junction / Q000187:drug effects*; D007263:Infusions, Parenteral; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology
D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol